Quarterly R&D expenses of ¥77 million
First written in FY2018-Q1. . Latest entry: FY2026.
58 other companies' latest entry also says "Other".
- FY2026Increase in annual R&D expensesAnnual report
「R&D expenses for the fiscal year were ¥612 million.」
Full-year R&D expenses were ¥612 million, an increase from ¥572 million in the previous fiscal year. - FY2026-H1Interim R&D Expense UpdateAnnual report
「R&D expenses for the interim consolidated accounting period were ¥298 million.」
R&D expenses for the interim consolidated accounting period were stated as ¥298 million. - FY2025Increase in annual R&D expensesAnnual report
「R&D expenses for the fiscal year were ¥572 million.」
Full-year R&D expenses were ¥572 million, an increase from ¥521 million in the previous fiscal year. - FY2025-H1Interim R&D Expense UpdateAnnual report
「R&D expenses for the interim consolidated accounting period were ¥279 million.」
R&D expenses for the interim consolidated accounting period were stated as ¥279 million. - FY2024Increase in annual R&D expensesAnnual report
「R&D expenses for the fiscal year were ¥521 million.」
Full-year R&D expenses were ¥521 million, an increase from ¥491 million in the previous fiscal year. - FY2024-Q3Update to R&D expenses for the first 3 quartersAnnual report
「R&D expenses for the nine-month period ended Q3 were ¥379 million.」
R&D expenses for the nine-month period ended Q3 were stated as ¥379 million, and it was stated that there had been no material changes in R&D activities. - FY2024-Q2Second-quarter R&D expenses updatedAnnual report
「R&D expenses for the six-month period ended Q2 were ¥251 million.」
R&D expenses for the six-month period ended Q2 were stated as ¥251 million, and it was stated that there had been no material changes in R&D activities. - FY2024-Q1First-quarter R&D expenses updatedAnnual report
「R&D expenses for the three-month period ended Q1 were ¥124 million.」
R&D expenses for the three-month period ended Q1 were stated as ¥124 million. It was stated that there had been no material changes in R&D activities. - FY2023-Q3Update to R&D expenses for the first 3 quartersAnnual report
「R&D expenses for the nine-month period ended Q3 were ¥358 million.」
R&D expenses for the nine-month period ended Q3 were stated as ¥358 million, and it was stated that there had been no material changes in R&D activities. - FY2023-Q2Second-quarter R&D expenses updatedAnnual report
「R&D expenses for the six-month period ended Q2 were ¥221 million.」
R&D expenses for the six-month period ended Q2 were stated as ¥221 million. - FY2023-Q1Update to quarterly R&D expensesAnnual report
「R&D expenses for the three-month period ended Q1 were ¥110 million.」
R&D expenses for the three-month period ended Q1 were stated as ¥110 million. - FY2022Update and increase in annual R&D expensesAnnual report
「R&D expenses for the fiscal year were ¥442.109 million.」
Full-year R&D expenses were ¥442 million, an increase from ¥405 million in the previous fiscal year. - FY2022-Q3Cumulative R&D expenditure updateAnnual report
「R&D expenses for the nine-month period ended Q3 were ¥327 million.」
R&D expenses for the nine-month period ended Q3 were stated as ¥327 million. - FY2022-Q2Cumulative R&D expenditure updateAnnual report
「R&D expenses for the cumulative consolidated period through the second quarter were ¥214 million.」
R&D expenses for the cumulative consolidated period through the second quarter were stated as ¥214 million. - FY2022-Q1Update to quarterly R&D expensesAnnual report
「R&D expenses for the cumulative consolidated period through the first quarter were ¥105 million.」
R&D expenses for the cumulative consolidated period through the first quarter were stated as ¥105 million. - FY2021Updated Annual R&D ExpensesAnnual report
「R&D expenses for the consolidated fiscal year were ¥405.110 million.」
Full-year R&D expenses were stated as ¥405 million, increasing from ¥384 million in the previous fiscal year. - FY2021-Q3Cumulative R&D expenditure updateAnnual report
「R&D expenses for the cumulative consolidated period through the third quarter were ¥299 million.」
R&D expenses for the cumulative consolidated period through the third quarter were stated as ¥299 million, and it was stated that there were no material changes in the status of R&D activities. - FY2021-Q2Cumulative R&D expenditure updateAnnual report
「R&D expenses for the cumulative consolidated period through the second quarter were ¥194 million.」
R&D expenses for the cumulative consolidated period through the second quarter were stated as ¥194 million, and it was stated that there were no material changes in the status of R&D activities. - FY2021-Q1Update to quarterly R&D expensesAnnual report
「R&D expenses for the cumulative consolidated period through the first quarter were ¥99 million.」
R&D expenses for the cumulative consolidated period through the first quarter were stated as ¥99 million. It was also stated that there were no material changes in the status of R&D activities. - FY2020Annual R&D expenditure updateAnnual report
「R&D expenses for the consolidated fiscal year were ¥384.379 million.」
Full-year R&D expenses were ¥384 million, increasing from ¥290 million in the previous fiscal year. - FY2020-Q3Cumulative R&D expenditure updateAnnual report
「R&D expenses for the cumulative consolidated period through the third quarter were ¥215 million.」
R&D expenses for the cumulative consolidated period through the third quarter were stated as ¥215 million, and it was stated that there were no material changes in the status of R&D activities. - FY2020-Q2Cumulative R&D expenditure updateAnnual report
「R&D expenses for the cumulative consolidated period through the second quarter were ¥143 million.」
R&D expenses for the cumulative consolidated period through the second quarter were stated as ¥143 million, and it was stated that there were no material changes in the status of R&D activities. - FY2020-Q1Update to quarterly R&D expensesAnnual report
「R&D expenses for the cumulative consolidated period through the first quarter were ¥70 million.」
R&D expenses for the cumulative consolidated period through the first quarter were stated as ¥70 million, and it was stated that there were no material changes in the status of R&D activities. - FY2019Updated Annual R&D ExpensesAnnual report
「R&D expenses for the consolidated fiscal year were ¥290.751 million.」
Full-year R&D expenses were stated as ¥290 million. - FY2019-Q3Cumulative R&D expenditure updateAnnual report
「R&D expenses for the cumulative consolidated period through the third quarter were ¥215 million.」
R&D expenses for the cumulative consolidated period through the third quarter were stated as ¥215 million, and it was stated that there were no material changes in the status of R&D activities. - FY2019-Q2Cumulative R&D expenditure updateAnnual report
「R&D expenses for the cumulative consolidated period through the second quarter were ¥141 million.」
R&D expenses for the cumulative consolidated period through the second quarter were stated as ¥141 million, and it was stated that there were no material changes in the status of R&D activities. - FY2019-Q1Update to quarterly R&D expensesAnnual report
「R&D expenses for the cumulative consolidated period through the first quarter were ¥70 million.」
R&D expenses for the cumulative consolidated period through the first quarter were stated as ¥70 million. - FY2018Annual R&D expenditure updateAnnual report
「R&D expenses for the consolidated fiscal year were ¥299 million.」
Full-year R&D expenses were stated as ¥299 million. - FY2018-Q3Cumulative R&D expenditure updateAnnual report
「R&D expenses for the cumulative consolidated period through the third quarter were ¥219 million.」
R&D expenses for the cumulative consolidated period through the third quarter were stated as ¥219 million, and it was stated that there were no material changes in the status of R&D activities. - FY2018-Q2Cumulative R&D expenditure updateAnnual report
「R&D expenses for the cumulative consolidated period through the second quarter were ¥147 million.」
R&D expenses for the cumulative consolidated period through the second quarter were stated as ¥147 million, and it was stated that there were no material changes in the status of R&D activities. - FY2018-Q1First statedAnnual report
「R&D expenses for the cumulative consolidated period through the first quarter were ¥77 million.」
R&D expenses for the cumulative consolidated period through the first quarter were stated as ¥77 million.